- Home
- ASTS vs RVMD Comparison
ASTS vs RVMD Comparison
Compare ASTS & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTS
- RVMD
- Stock Information
- Founded
- ASTS 2019
- RVMD 2014
- Country
- ASTS United States
- RVMD United States
- Employees
- ASTS N/A
- RVMD N/A
- Industry
- ASTS Telecommunications Equipment
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASTS Consumer Discretionary
- RVMD Health Care
- Exchange
- ASTS Nasdaq
- RVMD Nasdaq
- Market Cap
- ASTS 6.3B
- RVMD 7.5B
- IPO Year
- ASTS N/A
- RVMD 2020
- Fundamental
- Price
- ASTS $52.46
- RVMD $36.63
- Analyst Decision
- ASTS Buy
- RVMD Strong Buy
- Analyst Count
- ASTS 7
- RVMD 12
- Target Price
- ASTS $45.90
- RVMD $69.50
- AVG Volume (30 Days)
- ASTS 11.0M
- RVMD 1.5M
- Earning Date
- ASTS 08-11-2025
- RVMD 08-11-2025
- Dividend Yield
- ASTS N/A
- RVMD N/A
- EPS Growth
- ASTS N/A
- RVMD N/A
- EPS
- ASTS N/A
- RVMD N/A
- Revenue
- ASTS $4,636,000.00
- RVMD N/A
- Revenue This Year
- ASTS $1,331.30
- RVMD N/A
- Revenue Next Year
- ASTS $370.72
- RVMD $234.26
- P/E Ratio
- ASTS N/A
- RVMD N/A
- Revenue Growth
- ASTS 827.20
- RVMD N/A
- 52 Week Low
- ASTS $17.11
- RVMD $29.17
- 52 Week High
- ASTS $60.95
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- ASTS 54.87
- RVMD 40.62
- Support Level
- ASTS $51.30
- RVMD $36.60
- Resistance Level
- ASTS $55.78
- RVMD $38.10
- Average True Range (ATR)
- ASTS 3.71
- RVMD 1.22
- MACD
- ASTS -0.90
- RVMD -0.08
- Stochastic Oscillator
- ASTS 38.25
- RVMD 5.97
About ASTS AST SpaceMobile Inc.
AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building a cellular broadband network in space to operate directly with standard, unmodified mobile devices, and off-the-shelf mobile phones based on extensive IP and patent portfolio. It has focused on eliminating the connectivity gaps faced by mobile subscribers. The Company's spaceMobile Service is being designed to provide cost-effective, high-speed Cellular Broadband services to end-users who are out of terrestrial cellular coverage using existing mobile devices.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.